A new study led by researchers at the National Cancer Institute (NCI) shows that targeting an enzyme known as WRN may be a new method used to treat specific cancers. Over the previous year, "scientists discovered that cancers cells with a genetic feature called micro satellite instability-high (MSI-high) need WRN to survive." Approximately 1 in 3 endometrial, 1 in 7 colorectal, stomach, and ovarian cancers, are considered MSI-high.
To read more about this study, click here
No comments:
Post a Comment